RegistriesTissue DonorsHistocompatibility TestingTissue and Organ ProcurementHLA AntigensBlood DonorsLiving DonorsIncidenceTreatment OutcomeRisk FactorsTime FactorsRetrospective StudiesUnited StatesFollow-Up StudiesGraft SurvivalProspective StudiesKidney TransplantationTransplantation, HomologousCohort StudiesAge FactorsDenmarkLiver TransplantationSurvival RateRisk AssessmentNeoplasmsSEER ProgramSurvival AnalysisInfant, NewbornEuropeAge DistributionBone Marrow TransplantationTissue and Organ HarvestingHospital MortalityDatabases, FactualPrognosisNorwayProportional Hazards ModelsPatient SelectionRare DiseasesGraft RejectionSwedenMultivariate AnalysisCadaverAngioplasty, Balloon, CoronaryLogistic ModelsGraft vs Host DiseaseMyocardial InfarctionKaplan-Meier EstimateSex FactorsPopulation SurveillanceBrain DeathMedical Record LinkageGermanyItalyHistocompatibilityPostoperative ComplicationsFranceOdds RatioSex DistributionDrug-Eluting StentsBreast NeoplasmsCause of DeathHematopoietic Stem Cell TransplantationChi-Square DistributionRiskHospital RecordsDiseases in TwinsPrevalenceInsemination, Artificial, HeterologousJapanRecurrenceCase-Control StudiesSpainStrokePregnancy